Spine News and Research

RSS

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.

14 Feb 2013

ArthroCare fourth quarter total revenue increases 4.9% to $96.9 million

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2012.

14 Feb 2013

Misonix revenue increases 19% to $8.0M for six months ended December 31, 2012

Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.

7 Feb 2013

ACL injuries on the rise among young athletes

Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.

7 Feb 2013

Boston College biologist to explore connection between peripheral neuropathy and HIV

Boston College biologist Tricia Burdo has been awarded a five-year, $1.9 million grant from the National Institutes of Health to study the role of the body's immune response in a debilitating form of nerve damage suffered by people living with HIV.

6 Feb 2013

Spinal surgery outcomes put ‘July effect’ in myth category

The supposed commotion caused by an influx of new residents and fellows that typically takes place at teaching hospitals during the month of July has an negligible effect on periprocedural outcomes after spinal surgery.

4 Feb 2013

Dairy intake may increase risk of bone mineral density in the hip

A study by researchers at the Institute for Aging Research (IFAR) at Hebrew SeniorLife, an affiliate of Harvard Medical School (HMS), has found that dairy intake -specifically milk and yogurt -is associated with higher bone mineral density (BMD) in the hip, but not the spine.

1 Feb 2013

Zimmer fourth quarter net sales increase to $1.18 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2012. The Company reported fourth quarter net sales of $1.18 billion, an increase of 1.1% reported and 2.1% constant currency over the fourth quarter of 2011.

31 Jan 2013

Bilateral and multiple ‘popping’ characterizes upper cervical HVLA

Cavitation during upper cervical high-velocity, low amplitude thrust manipulation is significantly more likely to occur bilaterally than unilaterally, say investigators.

31 Jan 2013

Study finds negligible effect on periprocedural outcomes among patients after spine surgery

The "July effect"-the notion that the influx of new residents and fellows at teaching hospitals in July of each year adversely affects patient care and outcomes-was examined in a very large data set of hospitalizations for patients undergoing spine surgery. Researchers at the Mayo Clinic and the University of Virginia Health System found a negligible effect on periprocedural outcomes among patients treated by spine surgery.

30 Jan 2013

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable pain that can occur in people with advanced cancer, severe arthritis, and other extremely chronic conditions.

28 Jan 2013

Roundup: Lessons from Mass. health reform; Berwick moves closer to gov. bid; Jindal reverses Medicaid hospice cut

When Massachusetts adopted its landmark health care law in 2006, the goals were ambitious and the potential solutions complex. ... What are they getting in return?

25 Jan 2013

KLF6-SV1 gene variant drives the spread of breast cancer

A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and Erasmus Medical Center, have discovered a gene variant that drives the spread of breast cancer.

23 Jan 2013

Tall, thin women face increased risk of infection with nontuberculous mycobacteria

Tall, thin women face a greater risk of infection with nontuberculous mycobacteria (NTM), cousins of the organism that causes tuberculosis, according to researchers at National Jewish Health. Women with NTM infections also showed a weakened immune response associated with their fat cells, in a paper published in the Jan. 15, 2013, issue of The American Journal of Respiratory and Critical Care.

23 Jan 2013

Tumor separation surgery followed by SRS is safe and effective in controlling spinal metastases

Researchers from Memorial Sloan-Kettering Cancer Center (New York, NY) have found that tumor "separation surgery" followed by high-dose hypofractionated stereotactic radiosurgery (SRS) or high-dose single-fraction SRS is safe and effective in controlling spinal metastases regardless of the radiosensitivity of the particular tumor type that has invaded the spine.

23 Jan 2013

Russia approves FzioMed’s Oxiplex gel for lumbar spine surgery

FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the approval of Oxiplex in Russia. Oxiplex is an absorbable, clear, viscoelastic gel that is applied during lumbar spine surgery immediately prior to wound closure.

22 Jan 2013

Having two attending surgeons is better and safer during complex spinal surgeries

Two heads are better than one, as the saying goes - and a new study by a duo at the University of California, San Francisco (UCSF) demonstrates how having two attending surgeons in the operating room during spinal surgeries can benefit patients in multiple ways.

22 Jan 2013

BonAlive Biomaterials, Olympus Biotech sign multi-year exclusive distribution agreement

BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging leader in indications involving the treatment of chronically infected bone, and Olympus Biotech International Ltd, a wholly owned company of Olympus Corporation focused on minimally-invasive regenerative therapies in bone and soft tissues, today announced the signing of a multi-year exclusive distribution agreement.

From Evident Corporation - Life Sciences 21 Jan 2013

Having 2 attending physicians during spinal surgeries can benefit patients in multiple ways

19 Jan 2013

JNS publishes data from Providence’s DTRAX Facet Screw System clinical study

Providence Medical Technology, Inc. today announced the publication of the first peer-reviewed clinical paper describing the outcomes of the DTRAX Facet Screw System.

19 Jan 2013

Spine News and Research

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

ArthroCare fourth quarter total revenue increases 4.9% to $96.9 million

Misonix revenue increases 19% to $8.0M for six months ended December 31, 2012

ACL injuries on the rise among young athletes

Boston College biologist to explore connection between peripheral neuropathy and HIV

Spinal surgery outcomes put ‘July effect’ in myth category

Dairy intake may increase risk of bone mineral density in the hip

Zimmer fourth quarter net sales increase to $1.18 billion

Bilateral and multiple ‘popping’ characterizes upper cervical HVLA

Study finds negligible effect on periprocedural outcomes among patients after spine surgery

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

Roundup: Lessons from Mass. health reform; Berwick moves closer to gov. bid; Jindal reverses Medicaid hospice cut

KLF6-SV1 gene variant drives the spread of breast cancer

Tall, thin women face increased risk of infection with nontuberculous mycobacteria

Tumor separation surgery followed by SRS is safe and effective in controlling spinal metastases

Russia approves FzioMed’s Oxiplex gel for lumbar spine surgery

Having two attending surgeons is better and safer during complex spinal surgeries

BonAlive Biomaterials, Olympus Biotech sign multi-year exclusive distribution agreement

Having 2 attending physicians during spinal surgeries can benefit patients in multiple ways

JNS publishes data from Providence’s DTRAX Facet Screw System clinical study

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News